Therapy News and Research

RSS

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

The University of Maryland, Baltimore's (UMB) Office of Technology Transfer has completed a license agreement with Bali BioSciences LLC, an early-stage company pursuing an unusual, yet clever, strategy to combat disease.

20 Jan 2011

Post Acute Medical plans to expand Warm Springs Rehabilitation System with two new San Antonio hospitals

Post Acute Medical today announced plans to expand the Warm Springs Rehabilitation System with two new hospitals in San Antonio.

20 Jan 2011

Study validates MultiStem as potential stem cell therapy for spinal cord injury

Case Western Reserve University School of Medicine and Athersys, Inc. announced a joint scientific study on spinal cord injury will be published today in the January issue of The Journal of Neuroscience.

20 Jan 2011

TKA patients undergoing telerehabilitation experience similar results as traditional one: Study

Knee replacement patients undergoing telerehabilitation – a unique Internet-based postoperative rehabilitation program that can be conducted from the patient's home – experience the same results as patients who undergo traditional postoperative rehabilitation, according to a new study published in the Journal of Bone and Joint Surgery.

20 Jan 2011

4SC initiates dosing in resminostat Phase I/II SHORE study for KRAS-mutant colorectal cancer

4SC AG, a drug discovery and development company, today announced that the first patient has been dosed in the Phase I/II SHORE study with the oral pan-histone deacetylase (HDAC) inhibitor resminostat as a second-line treatment for patients with advanced and metastatic colorectal KRAS-mutant cancer.

20 Jan 2011

MD Anderson receives $150 million grant from Khalifa Foundation for cancer research

The Khalifa bin Zayed Al Nahyan Charity Foundation is granting $150 million to The University of Texas MD Anderson Cancer Center to support genetic-analysis based research, diagnosis and treatment of cancer.

20 Jan 2011

Endothelial cells may play a role in controlling cancer behavior: New study

MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.

20 Jan 2011

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Health care systems around the world are failing to use evidence obtained through research when making decisions, causing inefficiencies and reduced quantity and quality of life, according to a leading expert in the field of "knowledge translation."

20 Jan 2011

First group of patients 'graduate' from treatment at CDH Proton Center, A Procure Center

Two months after the opening of the CDH Proton Center, A ProCure Center, the first patients have "graduated" from their treatment surrounded by family, friends and staff. The group of graduating patients, whose tumors included prostate, brain and a non-cancerous tumor on the spinal cord, received proton therapy, an alternative to standard X-ray radiation that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

20 Jan 2011

Children's Hospital Los Angeles becomes only Autism Treatment Network site in California

Following a competitive application process, Michele D. Kipke, PhD, Vice Chair of Research for the Department of Pediatrics, Children's Hospital Los Angeles, was awarded a $420,000 grant which will allow the hospital to become part of the Autism Treatment Network (ATN) as an ATN Center of Clinical Excellence.

20 Jan 2011

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.

20 Jan 2011

Medicare's therapy policy under attack

Meanwhile, the AP reports on how some insurers are profiting from "playing the float."

20 Jan 2011

Roundup: Arizona Medicaid waiver?; 'Sweeping' Texas budget cuts; Wisconsin tort reform; Aspen's 'dismal' health coverage

The Legislature will meet in special session today to give Gov. Jan Brewer authority to seek a Medicaid waiver from the federal government, the first step to cutting health care for 280,000 Arizonans. Brewer and Republican lawmakers say the move is needed to balance the state budget and keep the rest of the state's Medicaid program intact.

20 Jan 2011

Positive top-line results from TC-5619 Phase 2 trial in patients with schizophrenia

Targacept, Inc. today announced positive top-line results from a Phase 2 clinical proof of concept trial to assess TC-5619 as an augmentation therapy to improve cognition in patients with schizophrenia.

20 Jan 2011

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology.

19 Jan 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

USPTO grants KL4 surfactant combination product patent to Discovery Labs

Discovery Laboratories, Inc. has been notified that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Number 7,863,241 titled "Compositions for Treatment and Prevention of Pulmonary Conditions." The patent provides broad coverage for compositions that employ a combination of certain pulmonary surfactants with a broad array of protease inhibitors, administered as either a liquid or aerosol, for treating pulmonary inflammation.

19 Jan 2011

Data on Ensituximab for treatment of pancreatic and colorectal cancers to be presented at ASCO 2011

Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.

19 Jan 2011

First Edition: January 19, 2011

Today's headlines and news coverage offer details about the House health law repeal debate, which started yesterday.

19 Jan 2011

National Jewish Health issued method patent for desensitizing B cells

National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department of Immunology at National Jewish Health, holds promise for treatment of B-cell mediated diseases, such as lymphoma and leukemia, rheumatoid arthritis, lupus and rejection of organ transplants.

19 Jan 2011

Therapy News and Research

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

Post Acute Medical plans to expand Warm Springs Rehabilitation System with two new San Antonio hospitals

Study validates MultiStem as potential stem cell therapy for spinal cord injury

TKA patients undergoing telerehabilitation experience similar results as traditional one: Study

4SC initiates dosing in resminostat Phase I/II SHORE study for KRAS-mutant colorectal cancer

MD Anderson receives $150 million grant from Khalifa Foundation for cancer research

Endothelial cells may play a role in controlling cancer behavior: New study

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

First group of patients 'graduate' from treatment at CDH Proton Center, A Procure Center

Children's Hospital Los Angeles becomes only Autism Treatment Network site in California

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Medicare's therapy policy under attack

Roundup: Arizona Medicaid waiver?; 'Sweeping' Texas budget cuts; Wisconsin tort reform; Aspen's 'dismal' health coverage

Positive top-line results from TC-5619 Phase 2 trial in patients with schizophrenia

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

Boston Scientific announces merger agreement to acquire Atritech

USPTO grants KL4 surfactant combination product patent to Discovery Labs

Data on Ensituximab for treatment of pancreatic and colorectal cancers to be presented at ASCO 2011

First Edition: January 19, 2011

National Jewish Health issued method patent for desensitizing B cells

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News